Postoperative Outcomes of One-Step Implant-Based Breast and Ovarian Surgery in High-Penetrance Gene Mutation: A Single-Center Experience
Open Access
- 7 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1784
Abstract
Background/Objectives: This study was designed to evaluate skin-sparing mastectomy with implant reconstruction complication rates in patients operated on due to high penetrant gene profile. All patients went to skin-sparing mastectomy with implant reconstruction and risk-reducing salpingo-oophorectomy. The effect of radiotherapy and chemotherapy on wound healing is a frequently discussed topic in the literature. However, studies on the effect of these on patients undergoing implant-based reconstruction are rare. In our clinic, two surgeries are performed under the same anesthesia and it is aimed to investigate the effect of this situation on complications in this rare patient group. In this retrospective study, we report our clinical experience regarding complication rates due to these factors among the high penetrant gene group. Methods: Between June 2022 and June 2024, 61 patients were grouped according to demographic data. Post-operative complications were defined as any of the following: major complications which were active bleeding or wound dehiscence; minor complications which were hematoma, seroma, surgical-site infection, <20% skin or nipple necrosis, and reoperation due to wound dehiscence or any other complication. Patients were compared in terms of complications according to whether they received previous radiotherapy (RT), neoadjuvant chemotherapy (CT), or underwent skin-reducing mammoplasty. Results: Patients receiving neoadjuvant chemotherapy, patients receiving preoperative RT, and patients undergoing skin-reducing mastectomy were compared in terms of major and minor complications. While neoadjuvant CT and preoperative RT only increased the risk of seroma, it was found that skin-reducing mastectomy had no significant effect on complication rates. Conclusions: Skin-sparing mastectomy with implant reconstruction and risk-reducing salphingo-oophorectomy is a comprehensive operation method in this patient group. Complication control can be achieved by performing two surgeries in a single anesthesia period, using the spy immunofluorescence device for vascularization control, and performing all surgeries with the same experienced team.Keywords
This publication has 21 references indexed in Scilit:
- Hereditary Breast CancerRadiologic Clinics of North America, 2024
- Risk‐reducing mastectomy decisions among women with mutations in high‐ and moderate‐ penetrance breast cancer susceptibility genesMolecular Genetics & Genomic Medicine, 2022
- Impact of neoadjuvant chemotherapy on surgical complications in breast cancer: A systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2022
- Skin Reducing Mastectomy and Immediate Tissue Expander ReconstructionAnnals of Plastic Surgery, 2021
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 WomenNew England Journal of Medicine, 2021
- Defining Infection in Breast ReconstructionAnnals of Plastic Surgery, 2018
- The Role of Genetic Testing in Patients With Breast CancerJAMA Surgery, 2017
- Impact of neoadjuvant chemotherapy on wound complications after breast surgerySurgery, 2012
- Impact of Chemotherapy on Postoperative Complications After Mastectomy and Immediate Breast ReconstructionArchives of Surgery, 2010
- Intravenous Fluorescein for Evaluating the Dusky Nipple-Areola during Reduction MammaplastyPlastic and Reconstructive Surgery, 1981